Mammary derived growth inhibitor (MDGI) is a member of the family of cytoplasmic fatty acid binding proteins (FABPs), which bind hydrophobic ligands such as fatty acids, retinoids, eicosanoids and prostaglandines. MDGI and an 11 amino acid MDGI-derived conserved Cterminal peptide (P108) inhibits growth of normal mammary epithelial cells in tissue and organ culture, but fails to inhibit proliferation of many breast cancer cell lines in vitro. Here, the eects of peptide P108 on tumor growth of MCF-7, MDA-MB468 and MDA-MB231 human breast cancer cell lines in nude mice were tested. To deliver P108 into tumors, a novel peptide production system was applied for expression and secretion of small bioactive peptides in mammalian cells. Functional dierentiation was observed in MCF-7 and MDA-MB468 cells upon P108 expression. In addition, EGF-dependent colony formation in soft agar by MDA-MB468 cells was inhibited by secreted P108. Tumor growth in athymic nude mice was suppressed in all three cell lines tested. Furthermore, P108 expressed by MCF-7/P108 cells caused paracrine tumor growth inhibition of MDA-MB231 cells. These results indicate that breast cancer inhibition by P108 is independent of binding to hydrophobic ligands and is perhaps mediated by interference with EGF-dependent signaling pathways.
Mammary derived growth inhibitor (MDGI) is a member of the family of cytoplasmic fatty acid binding proteins (FABPs), which bind hydrophobic ligands such as fatty acids, retinoids, eicosanoids and prostaglandines. MDGI and an 11 amino acid MDGI-derived conserved Cterminal peptide (P108) inhibits growth of normal mammary epithelial cells in tissue and organ culture, but fails to inhibit proliferation of many breast cancer cell lines in vitro. Here, the eects of peptide P108 on tumor growth of MCF-7, MDA-MB468 and MDA-MB231 human breast cancer cell lines in nude mice were tested. To deliver P108 into tumors, a novel peptide production system was applied for expression and secretion of small bioactive peptides in mammalian cells. Functional dierentiation was observed in MCF-7 and MDA-MB468 cells upon P108 expression. In addition, EGF-dependent colony formation in soft agar by MDA-MB468 cells was inhibited by secreted P108. Tumor growth in athymic nude mice was suppressed in all three cell lines tested. Furthermore, P108 expressed by MCF-7/P108 cells caused paracrine tumor growth inhibition of MDA-MB231 cells. These results indicate that breast cancer inhibition by P108 is independent of binding to hydrophobic ligands and is perhaps mediated by interference with EGF-dependent signaling pathways. Oncogene (2000) 19, 2455 ± 2460.
Keywords: growth inhibitor; peptide delivery; dierentiation; experimental therapy Endogenous growth inhibitors which function during normal tissue modeling are potentially valuable antitumor agents (Rytomaa and Toivonen, 1979) . In the mammary gland, several endogenous factors with growth inhibitory or dierentiation inducing activity on mammary epithelial cells have been characterized (Brandt and Ebert, 1998) . Examples are Mammastatin (Ervin et al., 1989) , neuregulin (NDF) (Peles et al., 1992) , transforming growth factor beta (TGF-b1) (Silberstein and Daniel, 1987) and MDGI (=heart FABP) (Boehmer et al., 1987; Grosse et al., 1992) . Cytoplasmic FABPs commonly bind hydrophobic ligands (Veerkamp et al., 1991; Boehmer et al., 1988) and mediate fatty acid metabolism and transport (Glatz et al., 1997) . MDGI was isolated from lactating mammary gland in a puri®cation scheme aimed at the identi®cation of growth inhibitory factors of the normal mammary gland (Boehmer et al., 1987) . MDGI is tightly regulated in the course of mammary gland morphogenesis, with highest protein levels during late pregnancy and lactation (Kurtz et al., 1990) , and expression is downregulated in a majority of human breast cancer samples, indicating tumor suppressor functions (Huynh et al., 1995 (Huynh et al., , 1996 Zschiesche et al., 1995) . MDGI induced functional dierentiation and suppressed ductal growth in primed mammary gland organ cultures (Yang et al., 1995) , and expression of cytoplasmic MDGI in MCF-7 cells reduced tumor growth (Huynh et al., 1995) .
The functions of MDGI during mammary gland morphogenesis and growth inhibition are not well understood and might be independent of ligand binding. MDGI is processed intracellularly into a Cterminally truncated isoform which is found with increasing abundance during late pregnancy (Brandt and Grosse, 1992) . This processing supposedly results in the release of a small peptide comprising the amino acid sequence downstream of the endopeptidic cleavage site (Figure 1a) . Indeed, earlier studies showed that a MDGI-derived 11 amino acid C-terminal peptide, designated as P108, mimics many of the eects of MDGI on mammary epithelial cells in culture (Yang et al., 1995; Kurtz et al., 1997) but is un®t to bind hydrophobic ligands (Wallukat et al., 1991) . The P108 sequence is contained within the fourth conserved exon of MDGI which encodes a 16 amino acid b-sheet structure located outside the ligand binding pocket (Treuner et al., 1994; Phelan et al., 1996; Billich et al., 1988) (Figure 1a) .
We set out to elucidate the consequences of peptide P108 release on cell dierentiation, cell proliferation and tumor growth. To produce P108 in vivo, we have used a cell based peptide production system which takes advantage of a naturally occurring mechanism for the production of the small peptide somatostatin from a precursor molecule in the hypothalamus, pancreatic D-cells and intestinal endocrine cells. The 11 amino acid peptide P108 was extended N-terminally to yield a 14 amino acid peptide to match the size of mature somatostatin (Figure 1a,b) . Correct processing of P108 from expression vector pPP108 was demonstrated by in vitro transcription-translation ( Figure 1c) . Production of an approximately 1.7 kD peptide was only observed in the presence of convertase containing membranes. Detection of a 10 kD band indicated propeptide release by signal sequence cleavage of the pre-pro-protein. The peptide delivery construct was transfected into the MDGI-negative human breast cancer cell lines MCF-7, MDA-MB468 and MDA-MB231. Stable cell clones were selected and production of P108 in all three cell lines was demonstrated by Northern analysis (Figure 2a ) and immunohistochemistry (Figure 2b ), using a peptide-speci®c anti-P108 antibody.
P108 enters cells rapidly and is active at very low concentrations in dierent in vitro assays (Wallukat et al., 1991) . The increasing abundance of this diusible endogenous molecule during late pregnancy perhaps signals induction of terminal dierentiation at this developmental stage. The eects of P108 on induction of b-casein expression and cell proliferation were studied in the transfected cell lines. Gross morphological observation showed that MDA-MB468/P108 cells extend cytoplasmic processes and appear more elongated than control cells. No morphological changes were observed in MCF-7/P108 and MDA-MB231/P108 cells (not shown). Functional dierentiation was indicated by increased b-casein expression in MDA-MB468/P108 and MCF-7/P108 cells (Figure 2c ), but not in MDA-MB231/P108 cells (not shown).
P108 expression did not result in inhibition of cell proliferation in all three breast cancer cell lines tested (data not shown). This is in agreement with previous ®ndings showing that MDGI as well as P108 strongly inhibit proliferation of non-transformed primary mammary epithelial cells, but fail to signi®cantly inhibit proliferation of most breast cancer cell lines in culture, including MaCa, MCF-7 and T47D (Kurtz et al., 1997; Treuner et al., 1994) .
Earlier results indicate that P108 acts as a functional antagonist for EGF and transforming growth factor-a (TGF-a) and reverses EGF induced proliferation and de-dierentiation of ductal epithelial cells in mouse mammary gland organ culture (Yang et al., 1995) . Since colony formation in soft agar by (Lassen et al., 1995) . The peptide region, which is encoded by the 4th exon, is depicted in black. Right panel: Sequence comparison of the peptide encoded by the most conserved exon 4 of MDGI in three dierent species. P108* shows the sequence expressed by the delivery system. The originally described P108 sequence is in bold. (b) The Pre-prosomatostatin based expression cassette for P108 (pPP108). HP: hinge peptide. The minimal peptide length of 70 amino acids needed for signal sequence mediated secretion rules out addition of a signal sequence (25 ± 40 amino acids) to P108 for secretion. Here, we have adopted the natural synthesis machinery for somatostatin. The 14 amino acid neuropeptide somatostatin is cleaved from a pre-propeptide in the Golgi-apparatus by ubiquitous subtilisin-type convertases (Brakch et al., 1995; Steiner et al., 1992) and subsequently secreted. Full length pre-prosomatostatin (PPS) cDNA from angler®sh (provided by Dr Dennis Shields, Albert Einstein College of Medicine of Yeshiva University, New York) was inserted into the BamHI site of pMC1neo, yielding pWPPS. Oligonucleotides coding for P108, the dibasic convertase cleavage site and downstream stop codons were inserted into an XmaI site of pWPPS immediately downstream of the convertase cleavage site. The Pre-Pro-P108 (PP108) insert was sequenced and subcloned into pcDNA3, yielding pPP108 (b). pPP0 is pcDNA3 containing only the pre-propeptide of angler®sh somatostatin from pWPPS, but no peptide sequences. (c) Processing of P108M in vitro. (+m) plus membranes, (7m) no membranes. 0.5 mg of pPP108M, a variant of pPP108 in which an additional methionine was C-terminally inserted into the P108 sequence to facilitate ecient labeling, were used for in vitro transcription/translation in the TNT T7 reticulocyte lysate system (Promega), containing 100 mCi Redivue L[ 35 S]Methionine (Amersham) in the presence or absence of convertase-containing canine pancreatic microsomal membranes (Promega) at 308C for 90 min. The translation products (prosomatostatin (10 kD) and P108M (1.7 kD)) were separated on a denaturing 16.5% Tris-Tricine SDS ± PAGE (Biorad). The gel was subsequently ®xed and Coomassie stained, destained, soaked in Ampli®er solution (Amersham) for 30 min, dried and exposed to Biomax (Kodak) at 7808C
MDA-MB468 cells is dependent on autocrine stimulation by EGF (Ennis et al., 1989) , we used these cells to test whether P108 expression inhibits colony formation. When MDA-MB468/P108 cells were plated in soft agar, colony formation was inhibited by 60% compared to control transfected cells (Figure 3a) . To examine whether secretion of P108 from a monolayer of P108-producer cells is sucient to inhibit colony formation in a paracrine manner, wild type MDA-MB468 indicator cells were plated on top of a monolayer of MDA-MB468/P108 cells. Colony formation was inhibited by about 30% in this crossfeeding assay. This inhibition was reversed by the addition of 5 ng/ml of EGF (Figure 3b) . A dose response curve was generated to estimate the P108 levels secreted by MDA-MB468/P108 cells. Synthetic P108 showed an inhibition of 30% at 10 79 M, and a maximal inhibition of about 75% at 10 77 M concentrations with an EC50 of approximately 10 78 M. The same activities were found for both, the 11 amino acid and the 14 amino acid P108 variants. These results indicate secretion of active peptide by MDA-MB468/ P108 cells comparable to a concentration of 10 79 M and suggest that P108 interacts with an EGF mediated pathway in these cells. It was shown previously that in neonatal rat myocytes, P108 reverses arachidonic acid and 15-hydroxyeicosatetraenoic acid (15-S-HETE) induced hypersensitation of b 2 -adrenergic receptors at 10 79 M concentrations (Wallukat et al., 1991) . It appears that in this model P108 acts downstream of the lipoxygenase (LOX) metabolite 15-S-HETE, perhaps by blocking its target. Indeed, activation of LOX-pathways plays a key role in basal and EGFinduced breast carcinogenesis (Natarajan and Nadler, Figure 1) . G418 (1 mg/ml) resistant cells were analysed by Northern blotting for P108 mRNA using an antisense oligonucleotide probe. For Northern blotting, RNA was isolated using RNAstat (Labtech). Twenty mg total RNA were separated on a denaturing 1% agarose formaldehyde, blotted on nylon membranes and hybridized with 32 P-labeled oligonucleotide probes for P108, and full length cDNA probes for MDGI, b-casein and glucose-6-phosphate dehydrogenase (GPDH). Membranes were washed at high stringency and exposed to Hyper®lm MP (Amersham). Cell clones with the highest mRNA expression levels were selected for further studies. (b) Immunohistochemistry for P108 in pPP108 transfected and pPP0 transfected control cells. pPP108 and pPP0 transfected cells were plated on chamber slides (Nunc), grown to subcon¯uency, ®xed in 4% paraformaldehyde for 20 min, followed by methanol/acetone for 30 s and washed in PBS. Immunohistochemistry was performed using peptide speci®c anity-puri®ed rabit anti-P108 antibodies (1 : 250) (Brandt and Grosse, 1992) and rabbit anti-b-casein antiserum (1 : 100) (provided by Dr David Salomon, NIH). Antibodies were applied to the cells and incubated for 45 min at room temperature. Slides were washed in PBS and PBS/0.05% Tween and blocked for 20 min in 5% goat serum. Biotinylated goat-anti rabbit antibodies (1 : 500) (Vector) were added for 45 min at RT. After washing in PBS, peroxidase conjugated avidin-biotin complexes (Vector) were applied for 45 min at RT followed by washing in PBS. The signal was detected using 3,3' diaminobenzidine (DAB) as substrate. Preimmunsera were used for controls. (c) Immunohistochemistry for b-casein in pPP108 transfected and pPP0 transfected cells 1998; Liu et al., 1996) . Interestingly, the antagonistic eect of P108 on EGF growth stimulation in organ culture is enhanced by the addition of arachidonic acid (Yang et al., 1995; Lehmann et al., 1989; Kurtz et al., 1997) .
To examine whether P108 aects tumor formation of breast cancer cells, we injected MCF-7/P108, MDA-MB468/P108 and MDA-MB231/P108 cells, and control transfected cells into athymic nude mice. MCF-7/P108 and MDA-MB468/P108 cell derived tumors degenerated completely after an initial growth phase. MDA-MB231/P108 tumors showed signi®-cantly delayed tumorigenesis and a slower growth rate than cells transfected with the empty vector (pcDNA3) and cells transfected with a construct that only expresses the pre-prosomatostatin protein, but no peptides (pPPO) (Figure 4a,b) . Northern analysis of MDA-MB231/P108 tumors showed continuing expression of P108 mRNA at day 14 (Figure 4d ). Histological analysis indicated decreased cell density and enhanced necrosis in tumors derived from cells that express P108 (not shown).
To study whether locally secreted P108 will also in¯uence tumor growth of non-transfected breast cancer cells, MCF-7/P108 and MCF-7/pcDNA3 cells were mixed with wild type MDA-MB231 breast cancer cells and the cell mixture was injected into athymic nude mice. Both groups initially showed similar tumor 3 MDA-MB468/P108 and control transfected MDA-MB468 cells were mixed with 3.6% agar as top layers and plated on top of the solidi®ed bottom agar. Cells were cultured at 378C and 5% CO 2 . Colonies were counted after 2 weeks using a colony counter (Omnicon 3600 Image analysis). For determination of a P108 dose-response curve, dierent concentrations of synthetic P108 peptide (Research Genetics) were added to the top layer at day 0 and day 7. For cross feeding, 10
4 MDA-MB468/P108 and control transfected MDA-MB468 cells were plated on 35 mm dishes. The following day, culture medium was removed and cells were covered with 6% bottom agar. Then, 2610 4 MDA-MB468 cells were mixed with 3.6% agar and plated on top of the solidi®ed bottom layer. Colonies were counted after 2 weeks. For testing epidermal growth factor (EGF)-reversion of P108 eects, 5 ng/ml of EGF was added to the top layer at days 0 and 7. All experiments were done in triplicates growth rates. Growth of tumors containing P108 producing cells ultimately stagnated and tumors even regressed (n=1), whereas tumors containing control cells continued to grow (Figure 4c ). Mixed cell tumors containing MDA-MB231 and MCF-7/P108 cells continue to express P108 mRNA for at least 14 days (Figure 4d ), indicating survival of MCF-7/P108 producing cells within the mixed tumor cell population.
The results show that active P108 was produced by an endogenous, self regenerating peptide delivery system at concentrations that facilitate paracrine ecacy of diusible peptide which resulted in signi®cant tumor growth inhibition. MDA-MB231+MCF-7/pcDNA3; lane 2: MDA-MB231+MCF-7/P108; lane 3: MDA-MB231/P108 only. Tumor growth of Estrogen-receptor (ER) positive MCF-7 and ER negative MDA-MB468 and MDA-MB231 cells was assayed in 6 ± 8 week old female athymic nude mice (NCR nu/nu, NCI) which received subcutaneous slow release estrogen pellets containing 0.01 mg 17b-estradiol at the time of implantation (for MCF-7 and MDA-MB468 cells). MDA-MB468 cells, although ER negative, show an increased tumor growth rate in the presence of estradiol, indicating sensitivity of these cells on systemic estrogen eects. Tumor size was measured in three dimensions using a caliper to calculate tumor volume. Each cell line was assayed in four mice. Each mouse received inframammary fat pad injections of cells on both sides (tumors: n=8). 5610 6 MCF-7/P108 and MDA-MB468/P108 and 2610 6 MDA-MB231/P108 cells, and control transfected cells were injected in 0.1 ml PBS. To elucidate paracrine eects of P108, MDA-MB231 cells were mixed with MCF-7/P108 and with control transfected MCF-7 cells at the following ratio: (i) 2.5610 6 MDA-MB231+2.5610 6 MCF-7/P108 and (ii) 2.5610 6 MDA-MB231+2.5610 6 MCF-7/pcDNA3 control cells. Three mice received bilateral subcutaneous injections (tumors: n=6). Animals were inspected twice weekly for 8 weeks. For histology and
